BioSpace News Archive

Although the size of the IPO is one aspect of determining the success of a company’s public launch, it’s not the only metric. How the stock does in the ensuing months is a very important consideration.

Aflac Incorporated, announced that it has further strengthened its longstanding distribution and business relationship with Japan Post Holdings Co., Ltd.

Concord Medical Services Holdings Limited, announced a topping out ceremony of Guangzhou Concord Cancer Center has been held at the construction site of the project.

Satralizumab monotherapy significantly reduced risk of relapse

Carmot Therapeutics announced today the initiation of a clinical trial for the treatment of type 2 diabetes with CT-868, a dual modulator of the GLP-1 and GIP incretin receptors.

Frelii Inc. today provided a shareholder update on the Company’s strategic roadmap detailing how it will further evolve its proprietary DNA profiling artificial intelligence (AI) to meet the growing demands of targeted market segments, including medical cannabis use analysis, telehealth and precision medicine, life and health insurance, consumer wellness and hospital systems.

The board of directors of Eli Lilly and Company (NYSE: LLY) today announced a 15 percent increase in its quarterly dividend. The dividend for the first quarter of 2019 will be $0.645 per share on outstanding common stock.

Two new studies associating dental amalgam fillings with pregnancy risks confirm action is urgently needed to protect babies from the known risks of mercury, according to the International Academy of Oral Medicine and Toxicology (IAOMT).

2019 revenue is expected to be between $25.3 billion and $25.8 billion, representing mid-single-digit growth driven by volume from newer medicines, including Trulicity, Taltz, Basaglar, Jardiance, Verzenio, Cyramza, Olumiant and Lartruvo, as well as the recent launch of Emgality.

Sutro develops successful spray drying technology marking a major advancement in commercial-scale manufacturing capabilities